<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">COVID-19 may augment complications in individuals with diabetes through an imbalance in ACE2 activation pathways leading to an inflammatory response and β-cell dysfunction in the pancreas, which may deteriorate COVID-19 complications including vasculopathy, coagulopathy and psychological stress [
 <xref ref-type="bibr" rid="CR49">49</xref>]. The chronic low grade inflammation in diabetes and obesity can also lead to an enhanced ‘cytokine storm’ in COVID-19 patients [
 <xref ref-type="bibr" rid="CR50">50</xref>].
</p>
